How long should we continue S-1 as adjuvant chemotherapy for squamous cell carcinoma of the head and neck?

Misato Hirai, Yorihisa Orita, Soshi Takao, Tomoyasu Tachibana, Hidenori Marunaka, Seiichiro Makihara, Kentaro Miki, Yasuyuki Noyama, Sayaka Fuji, Akiko Torigoe, Yasuharu Sato, Kazunori Nishizaki

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'How long should we continue S-1 as adjuvant chemotherapy for squamous cell carcinoma of the head and neck?'. Together they form a unique fingerprint.

Medicine & Life Sciences